Retatrutide for Weight Loss: What 2026 Research Shows About the Next-Generation Drug
Eli Lilly’s Retatrutide Hits Record Weight Loss, Challenges Surgery Efficacy | Whalesbook Retatrutide Is Producing Remarkable Weight-Loss Results The next generation of obesity medicines is moving quickly. One of the most closely watched candidates is retatrutide for weight loss, an experimental drug being developed by Eli Lilly. In May 2026, Lilly reported Phase 3 TRIUMPH-1 … Read more